1. Home
  2. GASS vs VNDA Comparison

GASS vs VNDA Comparison

Compare GASS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

BUY

Current Price

$9.22

Market Cap

319.4M

ML Signal

BUY

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

BUY

Current Price

$4.53

Market Cap

301.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GASS
VNDA
Founded
2004
2002
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.4M
301.1M
IPO Year
2005
2005

Fundamental Metrics

Financial Performance
Metric
GASS
VNDA
Price
$9.22
$4.53
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $11.75
AVG Volume (30 Days)
107.2K
★ 756.2K
Earning Date
11-24-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $216,105,000.00
Revenue This Year
N/A
$15.16
Revenue Next Year
N/A
$35.50
P/E Ratio
$5.00
★ N/A
Revenue Growth
N/A
★ 8.72
52 Week Low
$6.22
$4.27
52 Week High
$10.55
$9.91

Technical Indicators

Market Signals
Indicator
GASS
VNDA
Relative Strength Index (RSI) 49.30 31.06
Support Level $9.10 $4.45
Resistance Level $9.83 $5.37
Average True Range (ATR) 0.24 0.17
MACD -0.00 -0.06
Stochastic Oscillator 33.77 14.80

Price Performance

Historical Comparison
GASS
VNDA

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: